Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03193229 · ClinicalTrials.gov registry record · NA
MapTrek to Increase Activity Among Patients at Risk for Type 2 Diabetes
A NA study, sponsored by Philip Polgreen.
- Completed
- Registry status
- NA
- Development phase
- 430
- Enrollment target
NCT03193229: Completed NA study, sponsored by Philip Polgreen.
NCT03193229 is a NA study that has completed, run by Philip Polgreen. The registered enrollment target is 430 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03193229, a NA study, has completed, sponsored by Philip Polgreen.
- COMPLETED
- Registry status
- NA
- Development phase
- 430 participants
- Enrollment target
Study Summary
The overarching objective of our work is to provide an inexpensive and scalable m-health tool to increase both volume and intensity of physical activity and reduce sedentary behavior in patients at risk for type 2 diabetes. The objective of this study is to pilot test MapTrek, a text-messaging based intervention.
Primary Outcome
The Fitbit will provide the total number of steps that each patient has taken per day.
Interventions
- DEVICE Fitbit
- BEHAVIORAL MapTrek
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 430 participants |
| Start Date | 2017-05-15 |
| Est. Completion | 2018-05-04 |
| Phase | NA |
What the finished NCT03193229 record still lists
NCT03193229 is an interventional study that assigns participants to a tested intervention. The registered 430 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower).
The record links to 0 conditions, and to 2 interventions - of which Fitbit is the first listed.
NCT03193229 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03193229 about?
NCT03193229 is a clinical study titled "MapTrek to Increase Activity Among Patients at Risk for Type 2 Diabetes". The overarching objective of our work is to provide an inexpensive and scalable m-health tool to increase both volume and intensity of physical activity and reduce sedentary behavior in patients at risk for type 2 diabetes. The objective of this study is to pilot test MapTrek, a text-messaging based...
What is the current status of trial NCT03193229?
This trial is currently completed. It is a NA study. The enrollment target is 430 participants. The study started on 2017-05-15. Estimated completion is 2018-05-04.
What interventions are being tested in trial NCT03193229?
The interventions under investigation include: Fitbit (DEVICE), MapTrek (BEHAVIORAL).
Who is sponsoring clinical trial NCT03193229?
This trial is sponsored by Philip Polgreen, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03193229's enrollment target sits among peer trials
430 235th of 2000 higher than 1,765 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05327023 · 430 participants · Phase 1
Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
- NCT05457985 · 430 participants · NA
Testing Adaptive Interventions to Improve Posttraumatic Stress Disorder Treatment Outcomes in Federally Qualified Health Centers
- NCT05532982 · 430 participants
Parkinson's Disease in Asian Americans
- NCT05844891 · 430 participants · NA
Telehealth-Enhanced Asthma Care for Home After the Emergency Room
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI